These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

319 related articles for article (PubMed ID: 23858002)

  • 1. Mechanism of calsequestrin regulation of single cardiac ryanodine receptor in normal and pathological conditions.
    Chen H; Valle G; Furlan S; Nani A; Gyorke S; Fill M; Volpe P
    J Gen Physiol; 2013 Aug; 142(2):127-36. PubMed ID: 23858002
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Abnormal interactions of calsequestrin with the ryanodine receptor calcium release channel complex linked to exercise-induced sudden cardiac death.
    Terentyev D; Nori A; Santoro M; Viatchenko-Karpinski S; Kubalova Z; Gyorke I; Terentyeva R; Vedamoorthyrao S; Blom NA; Valle G; Napolitano C; Williams SC; Volpe P; Priori SG; Gyorke S
    Circ Res; 2006 May; 98(9):1151-8. PubMed ID: 16601229
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Calsequestrin 2 (CASQ2) mutations increase expression of calreticulin and ryanodine receptors, causing catecholaminergic polymorphic ventricular tachycardia.
    Song L; Alcalai R; Arad M; Wolf CM; Toka O; Conner DA; Berul CI; Eldar M; Seidman CE; Seidman JG
    J Clin Invest; 2007 Jul; 117(7):1814-23. PubMed ID: 17607358
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modulation of SR Ca release by luminal Ca and calsequestrin in cardiac myocytes: effects of CASQ2 mutations linked to sudden cardiac death.
    Terentyev D; Kubalova Z; Valle G; Nori A; Vedamoorthyrao S; Terentyeva R; Viatchenko-Karpinski S; Bers DM; Williams SC; Volpe P; Gyorke S
    Biophys J; 2008 Aug; 95(4):2037-48. PubMed ID: 18469084
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of calsequestrin, triadin, and junctin in conferring cardiac ryanodine receptor responsiveness to luminal calcium.
    Györke I; Hester N; Jones LR; Györke S
    Biophys J; 2004 Apr; 86(4):2121-8. PubMed ID: 15041652
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ablation of HRC alleviates cardiac arrhythmia and improves abnormal Ca handling in CASQ2 knockout mice prone to CPVT.
    Liu B; Ho HT; Brunello L; Unudurthi SD; Lou Q; Belevych AE; Qian L; Kim DH; Cho C; Janssen PM; Hund TJ; Knollmann BC; Kranias EG; Györke S
    Cardiovasc Res; 2015 Nov; 108(2):299-311. PubMed ID: 26410369
    [TBL] [Abstract][Full Text] [Related]  

  • 7. RYR2 Channel Inhibition Is the Principal Mechanism of Flecainide Action in CPVT.
    Kryshtal DO; Blackwell DJ; Egly CL; Smith AN; Batiste SM; Johnston JN; Laver DR; Knollmann BC
    Circ Res; 2021 Feb; 128(3):321-331. PubMed ID: 33297863
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Luminal Ca2+ regulation of single cardiac ryanodine receptors: insights provided by calsequestrin and its mutants.
    Qin J; Valle G; Nani A; Nori A; Rizzi N; Priori SG; Volpe P; Fill M
    J Gen Physiol; 2008 Apr; 131(4):325-34. PubMed ID: 18347081
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Viral gene transfer rescues arrhythmogenic phenotype and ultrastructural abnormalities in adult calsequestrin-null mice with inherited arrhythmias.
    Denegri M; Avelino-Cruz JE; Boncompagni S; De Simone SA; Auricchio A; Villani L; Volpe P; Protasi F; Napolitano C; Priori SG
    Circ Res; 2012 Mar; 110(5):663-8. PubMed ID: 22298808
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The cardiac ryanodine receptor luminal Ca2+ sensor governs Ca2+ waves, ventricular tachyarrhythmias and cardiac hypertrophy in calsequestrin-null mice.
    Zhang J; Chen B; Zhong X; Mi T; Guo A; Zhou Q; Tan Z; Wu G; Chen AW; Fill M; Song LS; Chen SR
    Biochem J; 2014 Jul; 461(1):99-106. PubMed ID: 24758151
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modulation of ryanodine receptor by luminal calcium and accessory proteins in health and cardiac disease.
    Györke S; Terentyev D
    Cardiovasc Res; 2008 Jan; 77(2):245-55. PubMed ID: 18006456
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevention of ventricular arrhythmia and calcium dysregulation in a catecholaminergic polymorphic ventricular tachycardia mouse model carrying calsequestrin-2 mutation.
    Alcalai R; Wakimoto H; Arad M; Planer D; Konno T; Wang L; Seidman JG; Seidman CE; Berul CI
    J Cardiovasc Electrophysiol; 2011 Mar; 22(3):316-24. PubMed ID: 20807279
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protein protein interactions between triadin and calsequestrin are involved in modulation of sarcoplasmic reticulum calcium release in cardiac myocytes.
    Terentyev D; Viatchenko-Karpinski S; Vedamoorthyrao S; Oduru S; Györke I; Williams SC; Györke S
    J Physiol; 2007 Aug; 583(Pt 1):71-80. PubMed ID: 17569730
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impaired calcium-calmodulin-dependent inactivation of Cav1.2 contributes to loss of sarcoplasmic reticulum calcium release refractoriness in mice lacking calsequestrin 2.
    Kryshtal DO; Gryshchenko O; Gomez-Hurtado N; Knollmann BC
    J Mol Cell Cardiol; 2015 May; 82():75-83. PubMed ID: 25758429
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modest reductions of cardiac calsequestrin increase sarcoplasmic reticulum Ca2+ leak independent of luminal Ca2+ and trigger ventricular arrhythmias in mice.
    Chopra N; Kannankeril PJ; Yang T; Hlaing T; Holinstat I; Ettensohn K; Pfeifer K; Akin B; Jones LR; Franzini-Armstrong C; Knollmann BC
    Circ Res; 2007 Sep; 101(6):617-26. PubMed ID: 17656677
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Abnormal calcium signaling and sudden cardiac death associated with mutation of calsequestrin.
    Viatchenko-Karpinski S; Terentyev D; Györke I; Terentyeva R; Volpe P; Priori SG; Napolitano C; Nori A; Williams SC; Györke S
    Circ Res; 2004 Mar; 94(4):471-7. PubMed ID: 14715535
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intra-sarcoplasmic reticulum Ca2+ oscillations are driven by dynamic regulation of ryanodine receptor function by luminal Ca2+ in cardiomyocytes.
    Stevens SC; Terentyev D; Kalyanasundaram A; Periasamy M; Györke S
    J Physiol; 2009 Oct; 587(Pt 20):4863-72. PubMed ID: 19703963
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Flecainide inhibits arrhythmogenic Ca2+ waves by open state block of ryanodine receptor Ca2+ release channels and reduction of Ca2+ spark mass.
    Hilliard FA; Steele DS; Laver D; Yang Z; Le Marchand SJ; Chopra N; Piston DW; Huke S; Knollmann BC
    J Mol Cell Cardiol; 2010 Feb; 48(2):293-301. PubMed ID: 19835880
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Unexpected structural and functional consequences of the R33Q homozygous mutation in cardiac calsequestrin: a complex arrhythmogenic cascade in a knock in mouse model.
    Rizzi N; Liu N; Napolitano C; Nori A; Turcato F; Colombi B; Bicciato S; Arcelli D; Spedito A; Scelsi M; Villani L; Esposito G; Boncompagni S; Protasi F; Volpe P; Priori SG
    Circ Res; 2008 Aug; 103(3):298-306. PubMed ID: 18583715
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of Ca(2+)-Dependent Protein-Protein Interactions within the Ca(2+) Release Units of Cardiac Sarcoplasmic Reticulum.
    Rani S; Park CS; Sreenivasaiah PK; Kim DH
    Mol Cells; 2016 Feb; 39(2):149-55. PubMed ID: 26674963
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.